Xaira Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 198

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $800M

  • Investors
  • 20

Xaira Therapeutics General Information

Description

Developer of an artificial intelligence platform designed for drug discovery and development. The company's platform integrates predictive and agentic AI models, virtual cell modeling, causal biological datasets, and high-throughput biology data analysis across the drug discovery and development process to support target identification, therapeutic design, patient stratification, and disease modeling, enabling pharmaceutical and biotechnology companies to make data-driven research decisions and improve the efficiency of developing new medicines.

Contact Information

Website
www.xaira.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 700 Gateway Boulevard, 4th Floor
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Corporate Office
  • 700 Gateway Boulevard, 4th Floor
  • South San Francisco, CA 94080
  • United States
+1 (650)

Xaira Therapeutics Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xaira Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 15-Aug-2025 $800M Completed Generating Revenue
1. Seed Round 23-Apr-2024 Completed Generating Revenue
To view Xaira Therapeutics’s complete valuation and funding history, request access »

Xaira Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Xaira Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Xaira Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence platform designed for drug discovery and development. The company's platform int
Drug Discovery
South San Francisco, CA
198 As of 2026

Vienna, Austria
 

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Xaira Therapeutics Competitors (60)

One of Xaira Therapeutics’s 60 competitors is Delta4, a Venture Capital-Backed company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Delta4 Venture Capital-Backed Vienna, Austria
Deep Genomics Venture Capital-Backed Toronto, Canada
Zephyr AI Venture Capital-Backed McLean, VA
Molecule.one Venture Capital-Backed Portola Valley, CA
InterAx Venture Capital-Backed Schlieren, Switzerland
You’re viewing 5 of 60 competitors. Get the full list »

Xaira Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xaira Therapeutics Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alternative Investment Management Family Office Minority
ARCH Venture Partners Venture Capital Minority
Breyer Capital Venture Capital Minority
Byers Capital Investment Advisory Family Office Minority
Deviation Capital Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

Xaira Therapeutics FAQs

  • When was Xaira Therapeutics founded?

    Xaira Therapeutics was founded in 2023.

  • Where is Xaira Therapeutics headquartered?

    Xaira Therapeutics is headquartered in South San Francisco, CA.

  • What is the size of Xaira Therapeutics?

    Xaira Therapeutics has 198 total employees.

  • What industry is Xaira Therapeutics in?

    Xaira Therapeutics’s primary industry is Drug Discovery.

  • Is Xaira Therapeutics a private or public company?

    Xaira Therapeutics is a Private company.

  • What is the current valuation of Xaira Therapeutics?

    The current valuation of Xaira Therapeutics is .

  • What is Xaira Therapeutics’s current revenue?

    The current revenue for Xaira Therapeutics is .

  • How much funding has Xaira Therapeutics raised over time?

    Xaira Therapeutics has raised $1.3B.

  • Who are Xaira Therapeutics’s investors?

    Alternative Investment Management, ARCH Venture Partners, Breyer Capital, Byers Capital Investment Advisory, and Deviation Capital are 5 of 20 investors who have invested in Xaira Therapeutics.

  • Who are Xaira Therapeutics’s competitors?

    Delta4, Deep Genomics, Zephyr AI, Molecule.one, and InterAx are some of the 60 competitors of Xaira Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process